Skip to main content
Premium Trial:

Request an Annual Quote

Strange Bedfellows, and All That

Here's a trio you don't seem team up every day: Newt Gingrich, John Kerry, and Oakland A's manager Billy Beane have jointly written an op-ed in the New York Times arguing that evidence-based medicine will be the only way to improve the US healthcare system. They say:

In the past decade, baseball has experienced a data-driven information revolution. Numbers-crunchers now routinely use statistics to put better teams on the field for less money. Our overpriced, underperforming health care system needs a similar revolution. ... Remarkably, a doctor today can get more data on the starting third baseman on his fantasy baseball team than on the effectiveness of life-and-death medical procedures.

They contend that turning medicine into a data-driven enterprise, rather than one based on subjective information, could turn around a system that frequently lets patients down.

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.